Research Use Only. Not for human or veterinary use. Not medical advice.

RC-TA1 · Immune Signaling Research

RC-TA1 vial (catalog image)

RC-TA1

Immune Signaling Research

Catalog code Research material Lyophilized format Single catalog presentation
Presentation

Vial sizes for laboratory supply, not a protocol.

Pricing
Sign in
Researcher pricing for approved accounts
In stock
As listed on the public catalog, Nov 17, 2026
Add to cart
0 25 50 75
59 of 100

Popularity

Moderate

Public interest index

Trending down-20% vs prior 30 days

Research: Literature Activity 8/10 · High (PubMed volume)

Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.

Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.

Publications per year

Unique PubMed records grouped by publication year — a volume index, not a quality rating.

PubMed counts

Last updated Nov 17, 2026. 972 unique records for "thymosin alpha-1" OR "thymosin alpha 1" OR "thymosin α1" OR "thymosin α-1" OR thymalfasin OR "thymosin A1" OR "Thymosin-alpha1". 2026 is a partial year. Brand names that appear in some records are not used on this page. Regulatory status outside the United States is not presented here as a use claim. Source on PubMed

Key specifications

Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.

Catalog title
RC-TA1 | Immune Signaling Research
Research focus
Immune Signaling Research
Also described as
Thymosin alpha-1 · thymalfasin
Format
Lyophilized research peptide
Catalog status
In stock (public listing)
Presentations
10 mg vial (catalog presentation)Catalog sizes, not a protocol
Molecular formula
C129H215N33O55PubChem CID 16130571
Molecular weight
3,108.3PubChem average; exact mass 3,107.5074829
Receptor context
Thymus-derived 28-residue, N-terminally acetylated peptide (synthetic form also called thymalfasin); immune-signaling research contextLiterature description; research context only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
PubMed records
972 uniqueQuery above, Nov 17, 2026

Catalog notes & use limitations

Research-catalog framing only. This section does not describe effects in people or study outcomes.

Catalog notes

Listed under Immune Signaling Research

RC-TA1 appears in the PEPTIDEA™ Immune & Inflammation Signaling Research collection with RC-KPV and RU-L37.

Synthetic thymosin alpha-1 / thymalfasin

The catalog identity is thymosin alpha-1. The synthetic form is also called thymalfasin in the literature. This page does not present regulatory status or brand names as a use claim.

Single catalog presentation

The public listing is a simple product. The 10 mg vial size is inferred from SKU RC-409-10 and is a presentation of the research material, not a protocol.

Use limitations

Research use only

Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.

No outcome or dosing information

This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.

Confirm details from primary sources

Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.

Specifications

Laboratory-catalog and public-chemistry details. Items without a cited source are marked.

Catalog titleRC-TA1 | Immune Signaling Research
CategoryImmune Signaling Research (Immune & Inflammation Signaling Research)
Associated namesThymosin alpha-1; thymosin α1; thymalfasin
FormatLyophilized research peptide
Public catalog statusIn stock (as of Nov 17, 2026)
Catalog presentations10 mg vial (catalog presentation) — sizes of the research material, not a use protocol
Molecular formulaC129H215N33O55 (PubChem CID 16130571, retrieved Nov 17, 2026)
Molecular weight3,108.3 (PubChem average; exact mass 3,107.5074829)
InChIKeyNZVYCXVTEHPMHE-ZSUJOUNUSA-N (PubChem)
Receptor contextPublished papers describe thymosin alpha-1 as a 28-amino-acid, N-terminally acetylated peptide derived from prothymosin α. The synthetic form is also called thymalfasin. That is an identity description, not a use claim. Brand names are not used on this page.
SequenceNot reproduced on this page. See primary literature and the PubChem record.
PricingVisible after researcher sign-in
PubChem CID 16130571 is listed under the title thymalfasin. Sequence is omitted on this page.

Research literature

These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.

Review

Low et al.

Annals of the New York Academy of Sciences · 1979
Early survey of thymosin research and T-cell maturation factors

This paper surveys early thymosin research, including evidence for a family of thymic factors studied in T-cell maturation.

Experimental findings and any clinical-context discussion in the paper are not restated on this page.

Experimental, animal model

McGillis, Hall, and Goldstein

The Journal of Immunology · 1983
Circadian measurements of thymosin alpha-1 in mice

This paper reported circadian-rhythm measurements of thymosin alpha-1 in normal and thymectomized mice.

Concentration findings and any other experimental results in the paper are not reproduced here.

Review

Ancell, Phipps, and Young

American Journal of Health-System Pharmacy · 2001
Review of thymosin alpha-1

This review surveys the published literature on thymosin alpha-1, including laboratory and clinical-research contexts described at the time.

Clinical inferences, protocols, and outcome figures cited in the review are not restated on this page.

Clinical research report

Liaw

Journal of Gastroenterology and Hepatology · 2004
Thymalfasin in adults with chronic hepatitis B — research-context report

This paper discusses thymalfasin (thymosin alpha-1) in adults with chronic hepatitis B, as described in the clinical research literature of the time.

Treatment-context language, protocols, and any results in the paper are not reproduced here.

Structural review

Hoch and Volk

Vitamins and Hormones · 2016
Structures of thymosin proteins

This review surveys the structures of thymosin proteins, including thymosin alpha-1, in a biochemical and structural-biology context.

Structural models and any functional inferences in the review are not restated as results on this page.

Review

Simonova et al.

International Journal of Molecular Sciences · 2025
Thymosin alpha-1 in an aging-biology literature survey

This review surveys published literature that discusses thymosin alpha-1 in aging-biology research contexts.

Aging-related inferences and any outcome figures cited in the review are not reproduced on this page.

Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query "thymosin alpha-1" OR "thymosin alpha 1" OR "thymosin α1" OR "thymosin α-1" OR thymalfasin OR "thymosin A1" OR "Thymosin-alpha1". Source on PubMed

Storage & handling

General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.

  • Handle as a lyophilized research material intended for laboratory use only.
  • Store according to the conditions printed on the label and in any compound document provided to approved researchers.
  • Protect closed vials from moisture and unnecessary temperature swings.
  • If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
  • This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.

Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.